Hip Implants Market is Tending to Register a Promising CAGR of 4.1% During Forecast 2019-2025


Market Highlights
Hip replacement is a surgical procedure in which the hip joint is replaced by a prosthetic implant, which is also known as hip prosthesis. Hip replacement surgery can be performed as a hemi (half) replacement or total replacement. The growth of the global hip implants market is driven by various factors, such as the introduction of custom-made implants and the growing geriatric population. Increased product launches, mergers, acquisitions, and partnerships of the major players of the market attributed to the growth of the market. However, stringent government regulations on all-metal hip implants and an increase in the number of product recalls are projected to hamper the growth of the global hip implants market.
According to MRFR analysis, the global Hip Implants Market is expected to register a CAGR of 4.1% during the forecast period of 2019 to 2025 and is expected to reach USD 9,300 million by 2025.
Several market players currently dominate the global hip implants market. The key players are involved in product launches and strategic collaborations to strengthen their market positions. For example, in May 2018, DePuy Synthes acquired Medical Enterprises Distribution, LLC, with its automated surgical impactor for hip replacement. Through this acquisition, the former developed and broadened the surgical impactor technology for a wide range of orthopedic surgery procedures.
Key Players
·         Corin
·         DJO Global
·         OMNILife science
·         MicroPort Scientific Corporation
·         Stryker Corporation
·         Zimmer Biomet Holdings
·         Smith & Nephew PLC
·         Exactech, Inc
·         B. Braun Melsungen AG
·         Aesculap Implant Systems
Segmentation
·         The global hip implants market has been segmented based on the product, material, and end user.
·         The market, based on product, has been divided into total hip replacement implants and partial hip replacement implants. Total hip replacement segment is further segmented into fixed-bearing hip implants and mobile-bearing total hip implants. The partial hip implants segment has been further bifurcated into hip resurfacing implants and revision hip replacement implants.
·         The global hip implants market has been segregated, based on material, into metal-on-polyethylene, metal-on-metal, ceramic-on-metal, ceramic-on-polyethylene, and ceramic-on-ceramic.
·         The end users in the market are hospitals, orthopedic clinics, ambulatory surgical centers, and others.
Regional Analysis
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the rising per capita healthcare expenditure. The hip implants market in the Americas has further been branched into North America and Latin America, with the North American market being divided into the US and Canada. The European hip implants market has been categorized as Western Europe and Eastern Europe. The Western European market has been further classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The hip implants market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the growing geriatric population and increasing demand for hip replacement surgeries, the market in Asia-Pacific is expected to be the fastest-growing.
The hip implants market in the Middle East & Africa has been divided into the Middle East and Africa.

Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more